Research articlePublished 2018

Total Glucosides of Paeony in Combination with Mizolastine Decreased Serum Concentrations of Il-17 And Il-25 in Patients with Chronic Autoimmune Urticaria: A 12-Week Study

Authors: Shuzhen Qi, Shuchang Hu, Min Zhou, Yingxia Gao, Yeli Wu, Zufeng Sun, Qingjie Hu

Journal of Clinical and Cellular Immunology

Volume 9 · Issue 6 · Pages 1–7

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objective: This study investigated total glucosides of paeony (TGP)'s effect on serum IL-17 and IL-25 concentrations in patients with chronic autoimmune urticaria (CAU).Methods: 71 autologous serum skin test (ASST)+CAU patients were randomized into two groups: 35 patients orally received 0.6g TGP t.i.d. plus 10 mg mizolastines once daily for 12 weeks (Treatment Group). The remaining 36 patients orally received 10 mg mizolastines once daily for 12 weeks (Control Group). Additionally, 60 ASSTchronic spontaneous urticaria patients were used for baseline comparison. Serum IL-17 and IL-25 concentrations were measured and compared between the Treatment Group, Control group and the ASST- patients at baseline; they were further measured and compared between the Treatment and Control groups at weeks 4 and 12.Results: Baseline serum IL-17 and IL-25 concentrations in the ASST+ patients (173.40 ± 76.33 pg/ml, 22.07 ± 11.41 pg/ml, respectively) were significantly higher than those in the ASST- patients (76.15 ± 91.04 pg/ml, 8.69 ± 10.00 pg/ml, respectively). Significantly lower concentrations of IL-17 (102.60 ± 42.39 vs. 149.00 ± 76.61, P=0.003) and IL-25 (10.92 ± 5.45 vs. 16.74 ± 9.34, P=0.003) were associated with the Treatment Group vs. the Control Group at week 12, but not at baseline or week 4. Finally, the Treatment Group had significantly decreased IL-17 and IL-25 concentrations vs baseline at week 12 but not week 4, whereas the Control Group's IL-17 and IL-25 concentrations didn't change significantly over the 12 weeks.Conclusion: TGP significantly decreased serum IL-17 and IL-25 concentrations in patient with CAU at week 12. This provided basis for exploring TGP as an alternative treatment for CAU.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Shuzhen Qi”
  • BylineArticles whose byline prints “Shuchang Hu”
  • BylineArticles whose byline prints “Min Zhou”
  • BylineArticles whose byline prints “Yingxia Gao”
  • BylineArticles whose byline prints “Yeli Wu”
  • BylineArticles whose byline prints “Zufeng Sun”
  • BylineArticles whose byline prints “Qingjie Hu”